---

Gaudium IVF & Women Health Limited important data points

---

---

---

---

Gaudium IVF & Women Health Limited IPO Pros & Cons

Strengths:

• Potential exposure to the fast‑growing assisted reproductive technology (ART) and women’s healthcare sector in India with expanding demand.
• Established hub‑and‑spoke network and expanding footprint across multiple states, enhancing accessibility.
• Strong brand recognition under an experienced management team led by founder‑promoter leadership.
• Fresh issue proceeds earmarked for new centre expansion and debt reduction, supporting growth.
• Benefiting from favourable demographic trends and rising fertility awareness in India.

Risks:

• Healthcare services are sensitive to operational, regulatory, and reputational risks that could affect performance.
• Reliance on specialised professionals creates execution and talent retention risks.
• Market competition and pricing pressure from larger healthcare chains can compress margins.
• Financial performance volatility and profitability may be uncertain, especially pre‑listing.
• Delay or uncertainty in final IPO pricing and subscription terms adds execution risk for investors.

Gaudium IVF & Women Health Limited Promoters – Pre offer equity (Approx)

Dr. Manika Khanna	~99.32%
Dr. Peeyush Khanna	~0.36%
Vishad Khanna	~0.30%

Gaudium IVF & Women Health Limited Lot Size details

Application Type	Lot Size	No. of Lots	No. of Shares	Investment Amount
Retail(Min)	–	1	–	₹ –
Retail (Max)	–	13	–	₹ –
Small HNI (Min)	–	14	–	₹ –
Small HNI (Max)	–	66	–	₹ –
Big HNI (Min)	–	67	–	₹ –

Lead Managers / Registrars of Gaudium IVF & Women Health Limited 

Lead / Book Running Lead Managers	Sarthi Capital Advisors Private Limited
Registrar (RTA)	Bigshare Services Private Limited

Founding Year of Gaudium IVF & Women Health Limited & Managing Director

Gaudium IVF & Women Health Limited was incorporated in the year 2009.

Dr. Manika Khanna is the Founder, Chairperson & Managing Director (MD/CEO) of the company.

Gaudium IVF & Women Health Limited FAQ

• Q1. What is the business of Gaudium IVF & Women Health Limited?

  It is a fertility and women’s health services provider operating a hub‑and‑spoke network of assisted reproductive technology clinics across India, offering IVF, ICSI, IUI and related care.

  Share on Facebook

  Post on X

  Follow us

  Save

• Q2. Why is the company raising funds via IPO?

  Gaudium IVF is raising funds via IPO to expand its centre network, set up new IVF clinics, and reduce borrowings.

  Share on Facebook

  Post on X

  Follow us

  Save

• Q3. What is the size of the issue and where will it list?

  The issue size of the IPO is approx ~2.08 crore equity shares. It will be listed on the BSE & NSE platform.

  Share on Facebook

  Post on X

  Follow us

  Save

• Q4. What are the risks to an investor?

  Key risks include sector regulatory changes, competition, execution challenges in expanding clinics and sensitivity to operational/medical outcomes.

  Share on Facebook

  Post on X

  Follow us

  Save

• Q5. What are the potential upsides?

  Upsides include strong growth potential from rising infertility treatment demand in India, expanding patient reach and scaling of pan‑India services.

  Share on Facebook

  Post on X

  Follow us

  Save

• Q6. How to apply for the IPO?

  You can apply through your broker or bank’s ASBA/UPI facility once the subscription window opens.

  Share on Facebook

  Post on X

  Follow us

  Save

• Q 7. When is the tentative listing date?

  Expected listing date is yet to be announced.

  Share on Facebook

  Post on X

  Follow us

  Save

For more amazing blogs click here (IPO Corner).